Stockscreener 앱 받기
27.45
1.79%
-0.415
전일 마감가:
$27.86
열려 있는:
$28.2
하루 거래량:
13,158
Relative Volume:
0.01
시가총액:
$2.61B
수익:
$47.30M
순이익/손실:
$-203.85M
주가수익비율:
-13.93
EPS:
-1.97
순현금흐름:
$-168.65M
1주 성능:
-0.51%
1개월 성능:
-8.68%
6개월 성능:
+122.98%
1년 성능:
+130.69%
1일 변동 폭
$27.45
$28.20
1주일 범위
$25.75
$28.30
52주 변동 폭
$6.76
$35.38
Scholar Rock Holding Corp Stock (SRRK) Company Profile
명칭
Scholar Rock Holding Corp
전화
857-259-3860
주소
301 BINNEY STREET, CAMBRIDGE, MA
SRRK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| SRRK | 27.45 | 2.61B | 47.30M | -203.85M | -168.65M | -1.97 |
| VRTX | 446.01 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 738.52 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 586.49 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 249.16 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 102.51 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Scholar Rock Holding Corp Stock (SRRK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-04-03 | 재개 | Piper Sandler | Overweight |
| 2022-09-19 | 재개 | H.C. Wainwright | Buy |
| 2022-07-12 | 개시 | Truist | Buy |
| 2022-03-23 | 개시 | H.C. Wainwright | Buy |
| 2021-12-22 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-11-19 | 개시 | Piper Sandler | Overweight |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2021-01-11 | 개시 | Credit Suisse | Outperform |
| 2021-01-06 | 개시 | JP Morgan | Overweight |
| 2020-03-12 | 개시 | Robert W. Baird | Outperform |
모두보기
Scholar Rock Holding Corp 주식(SRRK)의 최신 뉴스
FY2024 EPS Estimates for Scholar Rock Cut by HC Wainwright - Defense World
What is Wedbush’s Forecast for Scholar Rock FY2024 Earnings? - Defense World
Redmile Group, LLC Expands Stake in Scholar Rock Holding Corp - GuruFocus.com
OrbiMed Advisors LLC Adjusts Stake in Scholar Rock Holding Corp - GuruFocus.com
FY2024 Earnings Forecast for Scholar Rock Issued By Wedbush - MarketBeat
Analysts Set Expectations for Scholar Rock FY2024 Earnings - MarketBeat
FY2028 Earnings Forecast for Scholar Rock Issued By Wedbush - MarketBeat
HC Wainwright Comments on Scholar Rock Q3 Earnings - MarketBeat
Scholar Rock chief medical officer sells $63k in stock By Investing.com - Investing.com Australia
Scholar Rock (NASDAQ:SRRK) Stock Price Expected to Rise, HC Wainwright Analyst Says - Defense World
Scholar Rock chief medical officer sells $63k in stock - Investing.com
Scholar Rock Holding Corporation (NASDAQ:SRRK) Q3 2024 Earnings Call Transcript - Insider Monkey
Creative Planning Invests $115,000 in Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World
Scholar Rock Holding Corp (SRRK) Q3 2024 Earnings Call Highlights: Strategic Advances and Promising Study Results - GuruFocus.com
Scholar Rock Holding Corp (SRRK) Q3 2024 Earnings Call Highlights: Strategic Advances and ... - Yahoo Finance
FMR LLC Bolsters Position in Scholar Rock Holding Corp - GuruFocus.com
Scholar Rock Reports Third Quarter 2024 Financial Results and Highlights Business Progress - citybiz
Scholar Rock Holding Corp Reports Q3 2024 Net Loss of $64.5 Mill - GuruFocus.com
Scholar Rock Holding Corp (SRRK) Q3 2024: Everything You Need To Know Ahead Of Earnings - GuruFocus.com
Scholar Rock Holding Co. (NASDAQ:SRRK) Given Consensus Recommendation of “Buy” by Analysts - Defense World
Scholar Rock Holding Co. (NASDAQ:SRRK) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat
Scholar Rock (NASDAQ:SRRK) Earns “Outperform” Rating from Wedbush - Defense World
Scholar Rock (SRRK) Scheduled to Post Earnings on Tuesday - MarketBeat
Vanguard Group Inc's Strategic Acquisition in Scholar Rock Holdi - GuruFocus.com
Scholar Rock's (SRRK) Outperform Rating Reiterated at Wedbush - MarketBeat
Scholar Rock Announces New Preclinical Data for SRK-439 Showing Significant Lean Mass Increase and Enhanced Fat Mass Loss with Metformin - BioSpace
Scholar Rock to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Provide Business Update on November 12, 2024 - BioSpace
abrdn plc Raises Stock Holdings in Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
Scholar Rock to Participate in Upcoming Investor Conferences - BioSpace
Scholar Rock to Present New Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 39th Annual Meeting - sharewise
Stocks to Watch: Bitcoin, technology companies, medical research lead Nasdaq (Oct. 21-25) - The News Record
Scholar Rock Holding Co. (NASDAQ:SRRK) Shares Bought by E. Ohman J or Asset Management AB - MarketBeat
Dow Jones, S&P 500 fall amid rising oil prices; Scholar Rock jumps 300%, Apple and insurance stocks dip - MSN
Top 2 Health Care Stocks That May Fall Off A Cliff This Month - Benzinga
Scholar Rock Closes of Full Exercise of Option to Purchase Additional Shares in Public Offering - citybiz
Scholar Rock Announces Closing of Full Exercise of Option to Purchase Additional Shares in Public Offering - Business Wire
Should You Buy Scholar Rock Holding Corporation (SRRK) After Golden Cross? - Yahoo Finance
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - StockTitan
Scholar Rock Holding Co. (NASDAQ:SRRK) Shares Bought by Exchange Traded Concepts LLC - MarketBeat
AQR Capital Management LLC Has $331,000 Stock Holdings in Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World
Scholar Rock’s stock soars more than 315% on positive trial of treatment for spinal muscular atrophy - MSN
AQR Capital Management LLC Boosts Holdings in Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
Scholar Rock (NASDAQ:SRRK) PT Raised to $42.00 at Piper Sandler - Defense World
Analysts Set Scholar Rock Holding Co. (NASDAQ:SRRK) PT at $28.25 - Defense World
Scholar Rock Holding Corp (SRRK) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - SETE News
Keros Therapeutics Appoints Yung H. Chyung, M.D., as Chief Medical Officer - GlobeNewswire
Scholar Rock stock could benefit from Biohaven's Ph3 results, Truist raises potential rally outlook - Investing.com UK
H.C. Wainwright reiterates Scholar Rock Holding Corp (SRRK) rating to a Buy - Knox Daily
Piper Sandler raises Scholar Rock stock target By Investing.com - Investing.com UK
Piper Sandler Boosts Scholar Rock (NASDAQ:SRRK) Price Target to $42.00 - MarketBeat
SRRK’s Market Whiplash: 51.70% YTD Rise, 232.79% Rise in 30 Days - The InvestChronicle
Scholar Rock Holding Corp (SRRK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.42%
0.16%
자본화:
|
볼륨(24시간):